Hémopathies malignes et os (myélome exclu)

Revue du Rhumatisme (Edition Francaise)

Volumn 67, Issue 6, 2000, Pages 418-426

  Roux, Sophie ^a   Mariette, Xavier ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

ATL; B cell malignancy; H mopathie maligne B; Hypercalcemia; Hypercalc mie; Lymphoma; Lymphome; Ost olyse; PTH rP

Indexed keywords

EID: 0042481453     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1169-8330(00)80019-8     Document Type: Article

References (51)

1. Roodman GD. Mechanisms of bone lesions in multiple myeloma and lymphoma. Cancer. 80:1997;1557-1563.
2. Unni KK. Malignant lymphoma of bone. Unni KK. Dahlin's bone tumors. 1996;237-248 Lippincott-Raven, Philadelphia.
3. Reimer RR, Chabner BA, Young RC, Reddick R, Johnson RE. Lymphoma presenting in bone: results of histopathology, staging, and therapy. Ann Intern Med. 87:1977;50-55.
4. Braunstein EM, White SJ. Non-Hodgkin lymphoma of bone. Radiology. 135:1980;59-63.
5. Gaudin P, Rozand Y, Fauconnier J, Phelip X, Audran M, Auvinet B, et al. Les manifestations rhumatologiques des révélatrices de maladie de Hodgkin et de lymphomes malins non hodgkiniens. Résultats d'une enquête nationale de 146 observations. Rev Rhum [Éd Fr]. 62:1995;365-375.
6. Gaudin P, Juvin R, Rozand Y, Troussier B, Rose-Pitter L, Lebas JF, et al. Skeletal involvement as the initial disease manifestation in Hodgkin's disease: a review of 6 cases. J Rheumatol. 19:1992;146-152.
7. Pertuiset E. Manifestations ostéoarticulaires des hémopathies malignes (myélome exclu). Éditions techniques. Encycl Méd Chir. 1994;8 Elsevier, Paris- France. Hématologie 13-036-K-10, Appareil locomoteur, 14-027-A-20.
8. Moulopoulos LA, Dimopoulos MA. Magnetic resonance imaging of the bone marrow in hematologic malignancies. Blood. 90:1997;2127-2147.
9. Haussler MD, Fenstermacher MJ, Johnston DA, Harle TS. MRI of primary lymphoma of bone: cortical disorder as a criterion for differential diagnosis. J Magn Reson Imaging. 9:1999;93-100.
10. Ostrowski ML, Inwards CY, Strickler JG, Witzig TE, Wenger DE, Unni KK. Osseous Hodgkin disease. Cancer. 85:1999;1166-1178.
11. Jean-Baptiste G, Arfi S, Plumelle Y, Panelatti G, Mangin JL, Pascaline N. Les hypercalcémies des leucémies à lymphocytes T de l'adulte. Rev Rhum [Éd Fr]. 60:1993;292-298.
12. Yufu Y, Nonaka S, Nobunaga M. Adult T cell leukemia-lymphoma mimicking rheumatic disease [letter]. Arthritis Rheum. 30:1987;599-600.
13. Meyer R, Kieffer D, Vautravers P, Kuntz JL, Asch L. Bone involvement in chronic lymphoid leukemia. À propos of a case. Rev Rhum Mal Osteoartic. 47:1980;651-655.
14. Leone J, Vilque JP, Jolly D, Pignon B, Blaise AM, Pennaforte JL, et al. Effect of chlorambucil on bone mineral density in the course of chronic lymphoid leukemia. Eur J Haematol. 61:1998;135-139.
15. Blanche P, Ribrag V, Dreyfus F, Sicard D. Leucémie lymphoïde chronique avec atteinte osseuse [lettre]. Presse Méd. 24:1995;284.
16. Fain O, Turpin F, Marchese B, Meseure D, Lejeune F, Callard P, et al. Hypercalcémie au cours de la leucémie lymphoïde chronique. Deux nouvelles observations [lettre]. Ann Méd Interne. 142:1991;547-551.
17. Cohen LM, Hill MC, Siegel RS, Lande IM. CT manifestations of Richter syndrome. J Comput Assist Tomogr. 11:1987;1007-1008.
18. Brouet JC, Fermand JP, Laurent G, Grange MJ, Chevalier A, Jacquillat C, et al. The association of chronic lymphocytic leukaemia and multiple myeloma: a study of eleven patients. Br J Haematol. 59:1985;55-66.
19. Fudenberg HH, Virella G. Multiple myeloma and Waldenström macroglobulinemia: unusual presentations. Semin Hematol. 17:1980;63-79.
20. Leb L, Grimes ET, Balogh K, Merritt JA Jr. Monoclonal macroglobulinemia with osteolytic lesions: a case report and review of the literature. Cancer. 39:1977;227-231.
21. Vermess M, Pearson KD, Einstei AB, Fahey JL. Osseous manifestations of Waldenström's macroglobulinemia. Radiology. 102:1972;497-504.
22. Rossi JF, Chappard D, Marcelli C, Laplante J, Commes T, Baldet P, et al. Micro-osteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol. 76:1990;469-475.
23. Fernand JP. Macroglobulinémie de Waldenström. Encycl Méd Chir. 1992;6 Elsevier, Paris. Hématologie, 13013-E-10.
24. Ribard P, Le Bail-Darné JL. Manifestations rhumatologiques des leucémies à tricholeucocytes. de Sèze S, Ryckewaert A, Kahn MF, Kuntz D, Dryll A, Meyer O. L'Actualité rhumatologique 1990. 1990;22-34 Expansion Scientifique Française, Paris.
25. Herold CJ, Wittich GR, Schwarzinger I, Haller J, Chott A, Mostbeck G, et al. Skeletal involvement in hairy cell leukemia. Skeletal Radiol. 17:1988;171-175.
26. Blot E, Miquel J, Heron F, Tilly H, Levesque H, Courtois H. Sternum tumour revealing a chronic myeloid leukaemia [letter]. Br J Rheumatol. 37:1998;1353-1354.
27. Tricot G, Boogaerts MA, Broeckaert-Van Orshoven A, Criel A, Van Hoof A, Van den Berghe H. Hypercalcemia and diffuse osteolytic lesions in the acute phase of chronic myelogenous leukemia. A possible relation between lymphoid transformation and hypercalcemia. Cancer. 52:1983;841-845.
28. Le Bail-Darné JL, Cremer-Legmann F, Cywiner-Golenzer C. Aspects rhumatologiques de la myélofibrose. de Sèze S, Ryckewaert A, Kahn MF, Kuntz D, Dryll A, Meyer O. L'Actualité rhumatologique 1989. 1989;82-94 Expansion Scientifique Française, Paris.
29. Poullin P, Gabriel B. Myélofibrose primitive et lésions ostéolytiques [lettre]. Rev Rhum [Éd Fr]. 61:1994;560-562.
30. Taillan B, Brocq O, Ferrari E, Campagni JP, Garnier G, Dujardin P. Megakaryoblastic transformation of myeloid splenomegaly with hypercalcemia and pseudomyelomatosis osteolysis [letter]. Rev Rhum Mal Ostéoartic. 59:1992;455.
31. Rennie J, Auchterlaunie I. Rheumatological manifestations of the leukemias and graft vs host disease. Baillères Clin Rheumatol. 52:1991;231-251.
32. Marsh WL Jr, Bylund DJ, Heath VC, Anderson MJ. Osteoarticular and pulmonary manifestations of acute leukemia. Case report and review of the literature. Cancer. 57:1986;385-390.
33. Rogalsky RJ, Black GB, Reed MH. Orthopaedic manifestations of leukemia in children. J Bone Joint Surg. 68A:1986;494-501.
34. Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P, et al. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol. 7:1989;1909-1914.
35. Chappard D, Rossi JF, Bataille R, Alexandre C. Osteoclast cytomorphometry demonstrates an abnormal population in B cell malignancies but not in multiple myeloma. Calcif Tissue Int. 48:1991;13-17.
36. Guise TA, Mundy GR. Cancer and bone. Endocr Rev. 19:1998;18-54.
37. Rossi JF, Bataille R, Chappard D, Alexandre C, Janbon C. B cell malignancies presenting with unusual bone involvement and mimicking multiple myeloma. Study of nine cases. Am J Med. 83:1987;10-16.
38. Thomas RJ, Guise TA, Yin JJ, Elliott J, Horwood NJ, Martin TJ, et al. Breast cancer cells interact with osteoblasts to support osteoclast formation. Endocrinology. 140:1999;4451-4458.
39. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone. 25:1999;109-113.
40. Franchini G. Molecular mechanisms of human T-cell leukemia/Lymphotropic virus type I infection. Blood. 86:1995;3619-3639.
41. Fetchick DA, Bertolini DR, Sarin PS, Weintraub ST, Mundy GR, Dunn JF. Production of 1,25-dihydroxyvitamin D3 by human T cell lymphotrophic virus-I-transformed lymphocytes. J Clin Invest. 78:1986;592-596.
42. Fukumoto S, Matsumoto T, Ikeda K, Yamashita T, Watanabe T, Yamaguchi K, et al. Clinical evaluation of calcium metabolism in adult T-cell leukemia/lymphoma. Arch Intern Med. 148:1988;921-925.
43. Dodd RC, Winkler CF, Williams ME, Bunn PA, Gray TK. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med. 146:1986;1971-1972.
44. Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab. 60:1985;29-33.
45. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomas. Blood. 82:1993;1383-1394.
46. Kremer R, Shustik C, Tabak T, Papavasiliou V, Goltzman D. Parathyroid-hormone-related peptide in hematologic malignancies. Am J Med. 100:1996;406-411.
47. Grill V, Rankin W, Martin TJ. Parathyroid hormone-related protein (PTH-rP) and hypercalcaemia. Eur J Cancer. 34:1998;222-229.
48. Firkin F, Seymour JF, Watson AM, Grill V, Martin TJ. Parathyroid hormone-related protein in hypercalcaemia associated with haematological malignancy. Br J Haematol. 94:1996;486-492.
49. Bacci G, Jaffe N, Emiliani E, van Horn J, Manfrini M, Picci P, et al. Therapy for primary non-Hodgkin's lymphoma of bone and a comparison of results with Ewing's sarcoma. Ten years' experience at the Istituto Ortopedico Rizzoli. Cancer. 57:1986;1468-1472.
50. Ralston SH, Thiébaud D, Herrmann Z, Steinhauer EU, Thürlimann B, Walls J, et al. Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia. Br J Cancer. 75:1997;295-300.
51. Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy. Br J Cancer. 72:1995;1289-1293.